Inventor · disambiguated record
Christos J. Petropoulos
Also filed as: PETROPOULOS CHRISTOS · PETROPOULOS CHRISTOS J · PETROPOULOS CHRISTOS JOHN
20 granted patents·15 pending applications·400 citations·filing 1997–2022
95Inventor score
Files withMONOGRAM BIOSCIENCES INC13VIROLOGIC INC6LABORATORY CORP AMERICA HOLDINGS4HUANG WEI2LAB CORP AMERICA HOLDINGS2
Top patents by PatentIndex Score
35 records- 0193US7169551B2Methods of evaluating viral entry inhibitors using patient derived envelope protein constructsMONOGRAM BIOSCIENCES INC·Filed 2005·Granted Jan 30, 2007·27 cites·71 claims
- 0293US5837464ACompositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screeningVIROLOGIC INC·Filed 1997·Granted Nov 17, 1998·175 cites·83 claims
- 0391US6242187B1Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screeningVIROLOGIC INC·Filed 1999·Granted Jun 5, 2001·83 cites·42 claims
- 0488US7097970B2Methods of evaluating viral entry inhibitors using patient derived envelope protein constructsMONOGRAM BIOSCIENCES INC·Filed 2001·Granted Aug 29, 2006·41 cites·36 claims
- 0586US7247439B1Method of evaluating a patient antibody response to envelope proteins of a virusMONOGRAM BIOSCIENCES INC·Filed 2002·Granted Jul 24, 2007·17 cites·31 claims
- 0685US7235356B2Methods of evaluating cell surface receptor binding of a patient derived population of viral envelope protein constructsMONOGRAM BIOSCIENCES INC·Filed 2005·Granted Jun 26, 2007·9 cites·20 claims
- 0784US11459624B2Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assaysMONOGRAM BIOSCIENCES INC·Filed 2020·Granted Oct 4, 2022·1 cites·15 claims
- 0883US6942969B2Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screeningVIROLOGIC INC·Filed 2001·Granted Sep 13, 2005·7 cites·51 claims
- 0982US10550441B2Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assaysMONOGRAM BIOSCIENCES INC·Filed 2013·Granted Feb 4, 2020·2 cites·29 claims
- 1079US2023313327A1Compositions and Methods for Determining Resistance to Inhibitors of Virus Enter Using Recombinant Virus AssaysMONOGRAM BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1178US7384734B2Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitorsMONOGRAM BIOSCIENCES INC·Filed 2003·Granted Jun 10, 2008·6 cites·19 claims
- 1277US7279279B2Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screeningMONOGRAM BIOSCIENCES INC·Filed 2004·Granted Oct 9, 2007·3 cites·23 claims
- 1376US8603736B2Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assaysPETROPOULOS CHRISTOS J·Filed 2005·Granted Dec 10, 2013·5 cites·29 claims
- 1473US9841425B2Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assaysMONOGRAM BIOSCIENCES INC·Filed 2015·Granted Dec 12, 2017·1 cites·27 claims
- 1572US7993824B2Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitorsMONOGRAM BIOSCIENCES INC·Filed 2003·Granted Aug 9, 2011·2 cites·35 claims
- 1666US9581595B2Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapyHUANG WEI·Filed 2008·Granted Feb 28, 2017·2 cites·32 claims
- 1763US9175355B2Methods for determining the presence of antibodies blocking viral infectionRICHMAN DOUGLAS·Filed 2009·Granted Nov 3, 2015·0 cites·23 claims
- 1863US2019025305A1Compositions and Methods for Evaluating Viral Receptor/Co-Receptor Usage and Inhibitors of Virus Entry Using Recombinant Virus AssaysMONOGRAM BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 1962US12366581B2Methods, compositions, and systems for detecting coronavirus neutralizing antibodiesLABORATORY CORP AMERICA HOLDINGS·Filed 2021·Granted Jul 22, 2025·0 cites·17 claims
- 2062US2005074888A1Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the sameVIROLOGIC INC·Filed 2003·Application pending·0 cites
- 2157US6489098B1Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDSVIROLOGIC INC·Filed 1999·Granted Dec 3, 2002·17 cites·13 claims
- 2257US2012276522A1Methods and Compositions for Determining Virus Susceptibility to Integrase InhibitorsHUANG WEI·Filed 2012·Application pending·0 cites
- 2355US10358683B2Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapyLABORATORY CORP AMERICA HOLDINGS·Filed 2017·Granted Jul 23, 2019·0 cites·20 claims
- 2454US2003013079A1Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the sameFiled 2001·Application pending·0 cites
- 2553US7553618B2Method for determining human immunodeficiciency virus type 1 (HIV-1) hypersusceptibility to the protease inhibitor amprenavirMONOGRAM BIOSCIENCES INC·Filed 2003·Granted Jun 30, 2009·2 cites·6 claims
- 2653US2016312315A1Methods and Compositions for Determining Virus Susceptibility to Integrase InhibitorsLABORATORY CORP AMERICA HOLDINGS·Filed 2016·Application pending·0 cites
- 2752US2004063191A1Compositions and methods for determining the replication capacity of a pathogenic virusFiled 2003·Application pending·0 cites
- 2850US2013274276A1Methods and compositions for determining virus susceptibility to non-nucleoside reverse transcriptase inhibitorsLAB CORP AMERICA HOLDINGS·Filed 2013·Application pending·0 cites
- 2949US2024011992A1Methods, Compositions, and Systems for Modulation of Coronavirus InfectionLABORATORY CORP AMERICA HOLDINGS·Filed 2021·Application pending·0 cites
- 3048US2005214743A1Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assaysVIROLOGIC INC·Filed 2003·Application pending·0 cites
- 3148US2004110125A1Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assaysFiled 2002·Application pending·0 cites
- 3247US2015065381A1Methods of identifying novel hiv-1 immunogensINT AIDS VACCINE INITIATIVE·Filed 2014·Application pending·0 cites
- 3346US2005214749A1Method for determining reduced susceptibility of HIV to protease inhibitor treatmentCHAPPEY COLOMBE·Filed 2005·Application pending·0 cites
- 3445US2013302782A1Methods for the Phenotypic Detection of HCV Inhibitor Resistant SubpopulationsLAB CORP AMERICA HOLDINGS·Filed 2012·Application pending·0 cites
- 3538US2009215028A1Methods and Compositions for Determining Anti-HIV Drug Susceptibility and Replication Capacity of HIVPAXINOS ELLEN·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christos J. Petropoulos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →